Guidance for industry [electronic resource] : providing clinical evidence of effectiveness for human drug and biological products
- Bib ID:
- 4780361
- Format:
- Book
- Online Access:
- http://purl.access.gpo.gov/GPO/LPS119052
Broken link? let us search Trove , the Wayback Machine , or Google for you.
- Description:
-
- Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, [1998]
- 1 online resource (20 p.)
- Notes:
-
- "Clinical 6."
- "May 1998."
- Subject:
- Other authors/contributors:
- Also Titled:
- Providing clinical evidence of effectiveness for human drug and biological products
- Govt. Doc. Number:
- HE 20.4702:EF 3
- Copyright:
-
In Copyright
You may copy under some circumstances, for example you may copy a portion for research or study. Order a copy through Copies Direct to the extent allowed under fair dealing. Contact us for further information about copying.
- Reason for copyright status:
- Until 2068 [Created/Published Date + 70 Years]
Copyright status was determined using the following information:
- Material type:
- Literary Dramatic Musical
- Published status:
- Published
- Publication date:
- 1998
Copyright status may not be correct if data in the record is incomplete or inaccurate. Other access conditions may also apply. For more information please see: Copyright in library collections.
Feedback
Similar items
- Guidance for industry [electronic resource] : changes to an approved application for specified biotechnology and specified synthetic biological products
- Guidance for industry [electronic resource] : qualifying for pediatric exclusivity under section 505A of the Federal Food, Drug, and Cosmetic Act
- Guidance for industry [electronic resource] : acute bacterial sinusitis, developing drugs for treatment
- Guidance for industry [electronic resource] : nonclinical safety evaluation of pediatric drug products
- Guidance for industry [electronic resource] : acute bacterial otitis media, developing drugs for treatment